Sodium hydrosulfide → Tert-butyl (6-(3-isopropylisothiazol-5-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methylcarbamate

HRID 40323

Reaktionsgleichung

Reaktionsgleichung von HRID 40323
[CH3:1][CH:2]([CH3:25])[C:3](=O)[C:4]#[C:5][C:6]1[CH:7]=[CH:8][C:9]2[N:10]([C:12]([CH2:15][NH:16][C:17](=[O:23])[O:18][C:19]([CH3:22])([CH3:21])[CH3:20])=[N:13][N:14]=2)[N:11]=1.[NH2:26]OS(O)(=O)=O.C(=O)(O)[O-].[Na+].[SH-:37].[Na+]>O.O1CCOCC1>[CH:2]([C:3]1[CH:4]=[C:5]([C:6]2[CH:7]=[CH:8][C:9]3[N:10]([C:12]([CH2:15][NH:16][C:17](=[O:23])[O:18][C:19]([CH3:22])([CH3:21])[CH3:20])=[N:13][N:14]=3)[N:11]=2)[S:37][N:26]=1)([CH3:25])[CH3:1]

Komponenten

7

Reaktionsbedingungen

Temperatur
0 °C

Versuchsvorschrift

An aqueous mixture of tert-butyl (6-(4-methyl-3-oxopent-1-ynyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methylcarbamate (0.800 g, 2.33 mmol) and hydroxylamine-O-sulfonic acid (0.263 g, 2.33 mol) in water (8.0 mL) and 1,4-dioxane (8.0 mL) was stirred at 0° C. until complete consumption of the organic starting material was observed. The mixture was then carefully treated with solid sodium bicarbonate (0.196 g, 2.33 mmol), followed by treatment with 1.4 M aqueous sodium hydrosulfide (1.83 ml, 2.56 mmol). The reaction was stirred at room temperature overnight. The reaction mixture was diluted with water (20 mL) and extracted with DCM (40 mL), dried over sodium sulfate, filtered and concentrated in vacuo. The concentrated crude material was dissolved in minimal DCM and was purified via MPLC (eluting with 0-10% MeOH/NH4OH in DCM) to yield tert-butyl (6-(3-isopropylisothiazol-5-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methylcarbamate (0.196 g, 22.5% yield) with 82% purity. MS (ESI pos. ion) m/z: 433.0 (M+H). Calc'd Exact Mass for C21H20N8OS: 432.51.

Aufarbeitung

  1. stirringThe reaction was stirred at room temperature overnight
  2. extractionextracted with DCM (40 mL)
  3. dry with materialdried over sodium sulfate
  4. filtrationfiltered
  5. concentrationconcentrated in vacuo
  6. concentrationThe concentrated crude material
  7. dissolutionwas dissolved in minimal DCM
  8. customwas purified via MPLC (eluting with 0-10% MeOH/NH4OH in DCM)

Quellen und Nachweise

ORD-Eintrag
ord-84b100fdd9184ffd8bde5a7439fd78ed
Quelldatensatz
uspto-grants-2013_09
Patentnummer
US08524900B2

Verknüpfte Notizen

Wird geladen…